Top

Annals of Hematology

Published in:

01-05-2020 | Chronic Lymphocytic Leukemia | Letter to the Editor

Successful use of venetoclax for treatment of eosinophilic dermatosis of myeloproliferative disease in a patient with chronic lymphocytic leukemia

Authors: Gopisree Peringeth, Suchitra Sundaram, Paul Bogner, Elizabeth Conroy, Pallawi Torka

Published in: Annals of Hematology | Issue 5/2020

Excerpt

Dear Editor, …

Bairey O, Goldschmidt N, Ruchlemer R, Tadmor T, Rahimi-Levene N, Yuklea M, Shvidel L, Berrebi A, Polliack A, Herishanu Y, Israeli Chronic Lymphocytic Leukemia Study Group (ICLLSG) (2012) Insect-bite-like reaction in patients with chronic lymphocytic leukemia: a study from the Israeli Chronic Lymphocytic Leukemia Study Group. Eur J Haematol 89:491–496. https://doi.org/10.1111/ejh.12015 CrossRefPubMed

Byrd JA, Scherschun L, Chaffins ML, Fivenson DP (2001) Eosinophilic dermatosis of myeloproliferative disease: characterization of a unique eruption in patients with hematologic disorders. Arch Dermatol 137:1378–1380PubMed

Farber MJ, La Forgia S, Sahu J, Lee JB (2012) Eosinophilic dermatosis of hematologic malignancy. J Cutan Pathol 39:690–695. https://doi.org/10.1111/j.1600-0560.2012.01906.x CrossRefPubMed

Bari O, Cohen PR (2017) Eosinophilic dermatosis of hematologic malignancy mimicking varicella zoster infection: report in a woman with chronic lymphocytic leukemia and review of the literature. Dermatol Pract Concept 7:6–15. https://doi.org/10.5826/dpc.0703a02 CrossRefPubMedPubMedCentral

Seymour JF, Kipps TJ, Eichhorst B, Hillmen P, D’Rozario J, Assouline S, Owen C, Gerecitano J, Robak T, de la Serna J, Jaeger U, Cartron G, Montillo M, Humerickhouse R, Punnoose EA, Li Y, Boyer M, Humphrey K, Mobasher M, Kater AP (2018) Venetoclax-rituximab in relapsed or refractory chronic lymphocytic leukemia. N Engl J Med 378:1107–1120. https://doi.org/10.1056/NEJMoa1713976 CrossRefPubMed

Barzilai A, Shpiro D, Goldberg I, Yacob-Hirsch Y, Diaz-Cascajo C, Meytes D, Schiby R, Amariglio N, Trau H (1999) Insect bite–like reaction in patients with hematologic malignant neoplasms. Arch Dermatol 135:1503–1507. https://doi.org/10.1001/archderm.135.12.1503 CrossRefPubMed

Kim JE, Kim S-C (2018) Insect bite-like reaction with bullous lesions mimicking bullous pemphigoid in a patient with chronic lymphocytic leukemia. Ann Dermatol 30:468–472. https://doi.org/10.5021/ad.2018.30.4.468 CrossRefPubMedPubMedCentral

Butzmann CM, Kern JS, Stanislawski G, Meiss F (2014) Insect bite-like reaction in a patient with chronic lymphocytic leukemia. J Dtsch Dermatol Ges 12:734–737. https://doi.org/10.1111/ddg.12326 CrossRefPubMed

Blum RR, Phelps RG, Wei H (2001) Arthropod bites manifesting as recurrent bullae in a patient with chronic lymphocytic leukemia. J Cutan Med Surg 5:312–314. https://doi.org/10.1177/120347540100500406 CrossRefPubMed

10.

Lachowiez C, White K, Spurgeon S (2018) Exaggerated arthropod assault: eosinophilic dermatosis in a patient with small lymphocytic lymphoma. Clin Case Rep 6:1893–1895. https://doi.org/10.1002/ccr3.1723 CrossRefPubMedPubMedCentral

Title: Successful use of venetoclax for treatment of eosinophilic dermatosis of myeloproliferative disease in a patient with chronic lymphocytic leukemia
Authors: Gopisree Peringeth
Suchitra Sundaram
Paul Bogner
Elizabeth Conroy
Pallawi Torka
Publication date: 01-05-2020
Publisher: Springer Berlin Heidelberg
Keywords: Chronic Lymphocytic Leukemia
Sweet's Syndrome
Published in: Annals of Hematology / Issue 5/2020
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-020-03991-x

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Successful use of venetoclax for treatment of eosinophilic dermatosis of myeloproliferative disease in a patient with chronic lymphocytic leukemia

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2020

Radioimmunotherapy for mantle cell lymphoma: 5-year follow-up of 90 patients from the international RIT registry

Separase activity distribution can be a marker of major molecular response and proliferation of CD34+ cells in TKI-treated chronic myeloid leukemia patients

Significant differences in access to tests and treatments for multiple myeloma between public and private systems in Latin America. Results of a Latin American survey. GELAMM (Grupo de Estudio Latino Americano de Mieloma Múltiple)

JAK2 exon 12 mutations in cases with JAK2V617F-negative polycythemia vera and primary myelofibrosis

Pathophysiology and recent therapeutic insights of sickle cell disease

Residual disease by flow cytometry in patients with nucleophosmin-mutated acute myeloblastic leukemia

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page